Increase in bone mass and bone strength by Sambucus williamsii HANCE in ovariectomized rats

被引:45
作者
Xie, F
Wu, CF
Zhang, Y
Yao, XS [1 ]
Cheung, PY
Chan, ASC
Wong, MS
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
[2] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Inst Mol Technol Drug Discovery & Synth, Open Lab Chirotechnol, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Med & Mol Pharmacol, State Key Lab, Shenzhen 518057, Peoples R China
关键词
Sambucus williamsii; ovariectomized rat; bone mineral density; bone strength OPG; RANKL;
D O I
10.1248/bpb.28.1879
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Herbal Sambucus williamsii HANCE (SWH) is a folk medicine with a long history of safe use for treatment of bone fractures and joint diseases in China. The present study was designed to investigate if SWH extract could be used for treatment of postmenopausal osteoporosis. SWH extracts (30 or 60 mg/100 g body weight/d) were orally administrated to four-months-old ovariectomized (OVX) rats for 3 months. SWH extracts did not alter weight gain and uterus weight in OVX rats. SWH extracts significantly increased serum Ca levels (p<0.05, vs. OVX control group) as well as decreased urinary Ca excretion (p<0.01, vs. OVX control group) in OVX rats. The upregulation of serum alkaline phosphatase, serum osteocalcin as well as urinary deoxypyridinoline levels by OVX was suppressed by treatment with SWH extracts in rats (p<0.05, vs. OVX control group). SWH extract increased the stiffness of femur at both dosage (p<0.05, vs. OVX control group) and increased tibial bone mineral density at 60 mg/100 g body weight/d (p<0.05, vs. OVX control group) in OVX rats. Our results indicate that orally administrated SWH extracts can decrease urinary calcium excretion and bone turnover rate in OVX rats, resulting in positive effects on biomechanical strength of bone and bone mineral density. This study is the first to report that SWH could be considered as a potential candidate for management of postmenopausal osteoporosis. Then in vitro experiments were performed to determine the potential molecular mechanism of the anti-osteoporotic effect of SWH. Results suggested that chloroform fraction and ethyl acetate fraction of SWH can inhibit osteoclastogenesis osteoclast by modulating the expression of osteoprotegrin (OPG) and receptor activator of NFKB ligand (RANKL) mRNA in osteoblastic UMR 106 cells. Both of them increased OPG mRNA and decreased RANKL mRNA expression, resulting in a dose-dependent increase in OPG/RANKL mRNA ratio (p<0.01, vs. vehicle-treated). Taken together, SWH treatment can effectively suppress the OVX-induced increase in bone turnover and its effects might be mediated by a decrease in osteoclastogenesis.
引用
收藏
页码:1879 / 1885
页数:7
相关论文
共 44 条
  • [1] Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats
    Ahmadiani, A
    Fereidoni, M
    Semnanian, S
    Kamalinejad, M
    Saremi, S
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1998, 61 (03) : 229 - 235
  • [2] Biochemical markers of bone metabolism in animals: Uses and limitations
    Allen, MJ
    [J]. VETERINARY CLINICAL PATHOLOGY, 2003, 32 (03) : 101 - 113
  • [3] Anderson JJB, 1998, P SOC EXP BIOL MED, V217, P345, DOI 10.3181/00379727-217-44243
  • [4] Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content
    Arjmandi, BH
    Birnbaum, R
    Goyal, NV
    Getlinger, MJ
    Juma, S
    Alekel, L
    Hasler, CM
    Drum, ML
    Hollis, BW
    Kukreja, SC
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) : 1364S - 1368S
  • [5] Beral V, 1999, J Epidemiol Biostat, V4, P191
  • [6] Body JJ, 2002, BONE, V30, p75S
  • [7] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [8] *CHIN MAT MED STAT, 2000, CHIN BENC, P545
  • [9] Hormone replacement therapy: current controversies
    Davison, S
    Davis, SR
    [J]. CLINICAL ENDOCRINOLOGY, 2003, 58 (03) : 249 - 261
  • [10] DEMPSTER DW, 1995, BONE, V16, P157, DOI 10.1016/8756-3282(95)80027-N